FdaApplication
NDA 020255
Identifiers
- fda_app_no: NDA020255
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 1993-10-19 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | DOBUTAMINE HYDROCHLORIDE | EQ 50MG BASE/100ML | INJECTABLE;INJECTION |
| DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | DOBUTAMINE HYDROCHLORIDE | EQ 100MG BASE/100ML | INJECTABLE;INJECTION |
| DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | DOBUTAMINE HYDROCHLORIDE | EQ 400MG BASE/100ML | INJECTABLE;INJECTION |
| DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | DOBUTAMINE HYDROCHLORIDE | EQ 200MG BASE/100ML | INJECTABLE;INJECTION |
4 products